Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41100 Larissa, Greece.
Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, University Hospital of Larissa, 41100 Larissa, Greece.
Curr Oncol. 2021 May 14;28(3):1879-1885. doi: 10.3390/curroncol28030174.
Single nucleotide polymorphisms (SNPs) in DNA repair genes may predispose to urothelial carcinoma of the bladder (UCB). This study focused on three specific SNPs in a population with high exposure to environmental carcinogens including tobacco and alcohol. A case-control study design was used to assess for presence of XPC PAT +/-, XRCC3 Thr241Met, and ERCC2 Lys751Gln DNA repair gene SNPs in peripheral blood from patients with UCB and healthy individuals. One hundred patients and equal number of healthy subjects were enrolled. The XPC PAT +/+ genotype was associated with a 2-fold increased risk of UCB (OR = 2.16; 95%CI: 1.14-4; = 0.01). The -/+ and +/+ XPC PAT genotypes were more frequently present in patients with multiple versus single tumors ( = 0.01). No association was detected between ERCC2 Lys751Gln genotypes/alleles, and risk for developing UCB. Presence of the XRCC3 TT genotype (OR = 0.14; 95%CI:0.07-0.25; < 0.01) and of the T allele overall (OR = 0.26; 95%CI:0.16-0.41; < 0.01) conferred a protective effect against developing UCB. The XPC PAT -/+ and XRCC3 Thr241Met SNPs are associated with predisposition to UCB. The XPC PAT -/+ SNP is also an indicator of bladder tumor multiplicity, which might require a more individualized surveillance and treatment.
DNA 修复基因中的单核苷酸多态性 (SNP) 可能使个体易患膀胱癌。本研究关注了暴露于包括烟草和酒精在内的环境致癌物的人群中三种特定的 SNP。采用病例对照研究设计,评估膀胱癌患者和健康个体外周血中 XPC PAT +/-, XRCC3 Thr241Met 和 ERCC2 Lys751Gln 三种 DNA 修复基因 SNP 的存在情况。共纳入 100 名患者和 100 名健康对照者。XPC PAT +/+ 基因型与膀胱癌风险增加 2 倍相关(OR = 2.16;95%CI:1.14-4; = 0.01)。与单发肿瘤相比,多发肿瘤患者中 XPC PAT -/+ 和 +/+ 基因型更为常见( = 0.01)。未发现 ERCC2 Lys751Gln 基因型/等位基因与膀胱癌风险之间存在关联。携带 XRCC3 TT 基因型(OR = 0.14;95%CI:0.07-0.25; < 0.01)和 T 等位基因(OR = 0.26;95%CI:0.16-0.41; < 0.01)与膀胱癌发生风险降低相关。XPC PAT -/+ 和 XRCC3 Thr241Met SNP 与膀胱癌易感性相关。XPC PAT -/+ SNP 也是膀胱癌多发性的指标,可能需要更个体化的监测和治疗。